Comparison between Sunrest Lifescience IPO and Vrundavan Plantation IPO.
Sunrest Lifescience IPO is a SME Fixed Price IPO proposed to list at NSE SME while Vrundavan Plantation IPO is a SME Fixed Price proposed to list at BSE SME.
| Sunrest Lifescience IPO | Vrundavan Plantation IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Mark Corporate Advisors Pvt.Ltd. | Interactive Financial Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Svcm Securities Pvt.Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Sunrest Lifescience IPO is up to ₹10.30 Cr whereas the issue size of the Vrundavan Plantation IPO is up to ₹14.52 Cr. The final issue price of Sunrest Lifescience IPO is ₹84.00 per share and of Vrundavan Plantation IPO is ₹108.00 per share.
| Sunrest Lifescience IPO | Vrundavan Plantation IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹84.00 per share | ₹108.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1200 shares |
| Fresh Issue Size | 12,25,600 shares | 13,44,000 shares |
| Fresh Issue Size (Amount) | up to ₹10.30 Cr | up to ₹14.52 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 12,25,600 shares | 13,44,000 shares |
| Issue Size Total (Amount) | up to ₹10.30 Cr | up to ₹14.52 Cr |
Sunrest Lifescience IPO opens on Nov 07, 2023, while Vrundavan Plantation IPO opens on Oct 30, 2023. The closing date of Sunrest Lifescience IPO and Vrundavan Plantation IPO is Nov 09, 2023, and Nov 01, 2023, respectively.
| Sunrest Lifescience IPO | Vrundavan Plantation IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Nov 07, 2023 | Oct 30, 2023 |
| Issue Close | Nov 09, 2023 | Nov 01, 2023 |
| Basis Of Allotment (Tentative) | Nov 15, 2023 | Nov 05, 2023 |
| Initiation of Refunds (Tentative) | Nov 16, 2023 | Nov 06, 2023 |
| Credit of Share (Tentative) | Nov 17, 2023 | Nov 06, 2023 |
| Listing date (Tentative) | Nov 20, 2023 | Nov 06, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Sunrest Lifescience IPO P/E ratio is 12.33, as compared to Vrundavan Plantation IPO P/E ratio of 34.62.
| Sunrest Lifescience IPO | Vrundavan Plantation IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Sunrest Lifescience Limited Financial Information (Restated)Sunrest Lifescience Limited's revenue decreased by -8.32% and profit after tax (PAT) rose by 162.91% between the financial year ending with March 31, 2023 and March 31, 2022.
| Vrundavan Plantation Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 85.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.91 | 62.65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.33 | 34.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹36.05 Cr. | ₹57.59 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 53% | 8.35% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 98% | 6.71% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.64 | 0.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.81 | ₹0.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 65.59% | 4.19% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Sunrest Lifescience IPO Retail Individual Investors (RII) are offered 6,12,800 shares while in Vrundavan Plantation IPO retail investors are offered 6,12,800 shares. Qualified Institutional Buyers (QIB) are offered in Sunrest Lifescience IPO and in Vrundavan Plantation IPO.
| Sunrest Lifescience IPO | Vrundavan Plantation IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 65,600 shares | 72,000 shares |
| QIB | ||
| NII | 6,12,800 shares | 6,72,000 shares |
| RII | 6,12,800 shares | 6,72,000 shares |
| Employee | ||
| Others | ||
| Total | 12,25,600 shares | 13,44,000 shares |
Sunrest Lifescience IPO subscribed 48.54x in total, whereas Vrundavan Plantation IPO subscribed 18.57x.
| Sunrest Lifescience IPO | Vrundavan Plantation IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 29.17x | 11.60x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 65.74x | 25.51x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 48.54x | 18.57x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
